Involvement of the p110a isoform of PI3K in early development of mouse embryos

Molecular Reproduction and Development

Volumn 76, Issue 4, 2009, Pages 389-398

  Xu, Xiao Yan ^a   Zhang, Zhe ^a   Su, Wen Hui ^a   Zhang, Yang ^a   Feng, Chen ^a   Zhao, Hong Mei ^a   Zong, Zhi Hong ^a   Cui, Cheng ^a   Yu, Bing Zhi ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MATURATION PROMOTING FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE P110ALPHA SUBUNIT; PROTEIN KINASE B; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; 1 PHOSPHATIDYLINOSITOL 3 KINASE P110 SUBUNIT, MOUSE; 1-PHOSPHATIDYLINOSITOL 3-KINASE P110 SUBUNIT, MOUSE; ISOENZYME;

ANIMAL EXPERIMENT; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; ENZYME ACTIVE SITE; GENE SILENCING; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ANIMAL EMBRYO; CELL CYCLE; ENZYMOLOGY; FEMALE; GENETICS; METABOLISM; PHYSIOLOGY; PREGNANCY; RNA INTERFERENCE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL CYCLE; EMBRYO, MAMMALIAN; FEMALE; ISOENZYMES; MICE; PREGNANCY; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE;

EID: 65449123905     PISSN: 1040452X     EISSN: 10982795     Source Type: Journal    
DOI: 10.1002/mrd.20978     Document Type: Article

References (54)

1. Anderson KE, Jackson SP. 2003. Class I phosphoinositide 3-kinases. Int J Biochem Cell Biol 35:1028-1033.
2. Balla T, Downing GJ, Jaffe H, Kim S, Zolyomi A, Catt KJ. 1997. Isolation and molecular cloning ofwortmannin-sensitive bovine type III phosphatidylinositol 4-kinases. J Biol Chem 272: 18358-18366.
3. Bellacosa A, Testa JR, Staal SP, Tsichlis PN. 1991. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science (New York, NY) 254:274-277.
4. Bi L, Okabe I, Bernard DJ, Wynshaw-Boris A, Nussbaum RL. 1999. Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110alpha subunit of phosphoinositide 3-kinase. J Biol Chem 274:10963-10968.
5. Brennan P, Babbage JW, Burgering BM, Groner B, Reif K, Cantrell DA. 1997. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity 7:679-689.
6. Cantley LC. 2002. The phosphoinositide 3-kinase pathway. Science (New York, NY) 296:1655-1657.
7. Carnero A, Lacal JC. 1998. Wortmannin, an inhibitor of phosphatidylinositol 3-kinase, induces oocyte maturation through a MPF-MAPK-dependent pathway. FEBS Lett 422:155-159.
8. Collado M, Medema RH, Garcia-Cao I, Dubuisson ML, Barradas M, Glassford J, Rivas C, Burgering BM, Serrano M, Lam EW. 2000. Inhibition of the phosphoinositide 3-kinase pathway induces a senescence-like arrest mediated by p27Kip1. J Biol Chem 275:21960-21968.
9. Currie RA, Walker KS, Gray A, Deak M, Casamayor A, Downes CP, Cohen P, Alessi DR, Lucocq J. 1999. Role of phosphatidylinositol 3,4,5-trisphosphate in regulating the activity and localization of 3-phosphoinositide-dependent protein kinase-1. Biochem J 337:575-583.
10. De Nadai C, Huitorel P, Chiri S, Ciapa B. 1998. Effect of wortman- nin, an inhibitor of phosphatidylinositol 3-kinase, on the first mitotic divisions of the fertilized sea urchin egg. J Cell Sci 111: 2507-2518.
11. Feng C, Yu A, Liu Y, Zhang J, Zong Z, Su W, Zhang Z, Yu D, Sun QY, Yu B. 2007. Involvement of protein kinase B/AKT in early development of mouse fertilized eggs. Biol Reprod 77:560-568.
12. Franke TF, Kaplan DR, Cantley LC. 1997. PI3K: Downstream AKTion blocks apoptosis. Cell 88:435-437.
13. Fruman DA, Meyers RE, Cantley LC. 1998. Phosphoinositide kinases. Annu Rev Biochem 67:481 -507.
14. Gallicano GI, McGaughey RW, Capco DG. 1997. Activation of protein kinase C after fertilization is required for remodeling the mouse egg into the zygote. Mol Reprod Dev 46:587-601.
15. Gershon E, Galiani D, Dekel N. 2006. Cytoplasmic polyadenylation controls cdc25B mRNA translation in rat oocytes resuming meiosis. Reproduction (Camb, Engl) 132:21 -31.
16. Halet G, Viard P, Carroll J. 2008. Constitutive PtdIns(3,4,5)P3 synthesis promotes the development and survival of early mammalian embryos. Development (Camb, Engl) 135:425-429.
17. Han SJ, Vaccari S, Nedachi T, Andersen CB, Kovacina KS, Roth RA, Conti M. 2006. Protein kinase B/Akt phosphorylation of PDE3A and its role in mammalian oocyte maturation. EMBO J 25:5716-5725.
18. Hoshino Y, Sato E. 2008. Protein kinase B (PKB/Akt) is required for the completion of meiosis in mouse oocytes. Dev Biol 314:215-223.
19. Hu Q, Klippel A, Muslin AJ, Fantl WJ, Williams LT. 1995. Ras- dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science (New York, NY) 268:100-102.
20. Jackson LN, Larson SD, Silva SR, Rychahou PG, Chen LA, Qiu S, Rajaraman S, Evers BM. 2008. PI3K/Akt activation is critical for early hepatic regeneration after partial hepatectomy. Am J Physiol 294:G1401-1410.
21. Kandel ES, Skeen J, Majewski N, Di Cristofano A, Pandolfi PP, Feliciano CS, Gartel A, Hay N. 2002. Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage. Mol Cell Biol 22:7831-7841.
22. King RW, Jackson PK, Kirschner MW. 1994. Mitosis in transition. Cell 79:563-571.
23. Klippel A, Reinhard C, Kavanaugh WM, Apell G, Escobedo MA, Williams LT. 1996. Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signal-transducing kinase pathways. Mol Cell Biol 16:4117-H27.
24. Klippel A, Escobedo MA, Wachowicz MS, Apell G, Brown TW, Giedlin MA, Kavanaugh WM, Williams LT. 1998. Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation. Mol Cell Biol 18:5699-5711.
25. Knight ZA, Gonzalez B, Feldman ME, Zunder ER, Goldenberg DD, Williams O, Loewith R, Stokoe D, Balla A, Toth B, Balla T, Weiss WA, Williams RL, Shokat KM. 2006. A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell 125:733-747.
26. Kubo H, Hazeki K, Takasuga S, Hazeki O. 2005. Specific role for p85/p110beta in GTP-binding-protein-mediated activation ofAkt. Biochem J 392:607-614.
27. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
28. Lee S, Choi EJ, Jin C, Kim DH. 2005. Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line. Gynecol Oncol 97:26-34.
29. Li DM, Sun H. 1998. PTEN/MMAC1/TEP1 suppresses the tumori- genicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc Natl Acad Sci USA 95:15406-15411.
30. Lighten AD, Hardy K, Winston RM, Moore GE. 1997. Expression of mRNA for the insulin-like growth factors and their receptors in human preimplantation embryos. Mol Reprod Dev 47:134-139.
31. Lopez-Hernandez E, Santos E. 1999. Oncogenic Ras-induced germinal vesicle breakdown is independent of phosphatidylino- sitol 3-kinase in Xenopus oocytes. FEBS Lett 451:284-288.
32. Lu DP, Chandrakanthan V, Cahana A, Ishii S, O'Neill C. 2004. Trophic signals acting via phosphatidylinositol-3 kinase are required for normal pre-implantation mouse embryo development. J Cell Sci 117:1567-1576.
33. Manning BD, Cantley LC. 2007. AKT/PKB signaling: Navigating downstream. Cell 129:1261-1274.
34. Millar JB, Russell P. 1992. The cdc25 M-phase inducer: An unconventional protein phosphatase. Cell 68:407-410.
35. Obrig TG, Culp WJ, McKeehan WL, Hardesty B. 1971. The mechanism by which cycloheximide and related glutarimide antibiotics inhibit peptide synthesis on reticulocyte ribosomes. J Biol Chem 246:174-181.
36. Pene F, Claessens YE, Muller O, Viguie F, Mayeux P, Dreyfus F, Lacombe C, Bouscary D. 2002. Role ofthe phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma. Oncogene 21:6587-6597.
37. Riley JK, Carayannopoulos MO, Wyman AH, Chi M, RatajczakCK, Moley KH. 2005. The PI3K/Akt pathway is present and functional in the preimplantation mouse embryo. Dev Biol 284:377-386.
38. Riley JK, Carayannopoulos MO, Wyman AH, Chi M, Moley KH. 2006. Phosphatidylinositol 3-kinase activity is critical for glucose metabolism and embryo survival in murine blastocysts. J Biol Chem 281:6010-6019.
39. Shayesteh L, Lu Y, Kuo WL, Baldocchi R, Godfrey T, Collins C, Pinkel D, Powell B, Mills GB, Gray JW. 1999. PIK3CA is implcated as an oncogene in ovarian cancer. Nat Genet 21:99-102.
40. Shtivelman E, Sussman J, Stokoe D. 2002. A role for PI 3-kinase and PKB activity in the G2/M phase of the cell cycle. Curr Biol 12:919-924.
41. Smotrich DB, Stillman RJ, Widra EA, Gindoff PR, Kaplan P, Graubert M, Johnson KE. 1996. Immunocytochemical localization ofgrowth factors and their receptors in human pre-embryos and Fallopian tubes. Hum Reprod (Oxford, Engl) 11:184-190.
42. Stokoe D. 2005. The phosphoinositide 3-kinase pathway and cancer. Expert Rev Mol Med 7:1-22.
43. Stoyanov B, Volinia S, Hanck T, Rubio I, Loubtchenkov M, Malek D, Stoyanova S, Vanhaesebroeck B, Dhand R, Nurnberg B, et al. 1995. Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science (New York, NY) 269:690-693.
44. Sue AQAK, Fialkow L, Vlahos CJ, Schelm JA, Grinstein S, Butler J, Downey GP. 1997. Inhibition of neutrophil oxidative burst and granule secretion by wortmannin: Potential role of MAP kinase and renaturable kinases. J Cell Physiol 172:94-108.
45. Takahashi K, Yoshida N, Murakami N, Kawata K, Ishizaki H, Tanaka-Okamoto M, Miyoshi J, Zinn AR, Shime H, Inoue N. 2007. Dynamic regulation of p53 subnuclear localization and senescence by MORC3. Mol Biol Cell 18:1701-1709.
46. Vanhaesebroeck B, Waterfield MD. 1999. Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res 253: 239-254.
47. Vanhaesebroeck B, Higashi K, Raven C, Welham M, Anderson S, Brennan P, Ward SG, Waterfield MD. 1999. Autophosphorylation of p110delta phosphoinositide 3-kinase: A new paradigm for the regulation of lipid kinases in vitro and in vivo. EMBO J 18: 1292-1302.
48. Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, Driscoll PC, Woscholski R, Parker PJ, Waterfield MD. 2001. Synthesis and function of3-phosphorylated inositol lipids. Annu Rev Biochem 70:535-602.
49. Vanhaesebroeck B, Ali K, Bilancio A, Geering B, Foukas LC. 2005. Signalling by PI3K isoforms: Insights from gene-targeted mice. Trends Biochem Sci 30:194-204.
50. Yu JY, DeRuiter SL, Turner DL. 2002. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci USA 99:6047-6052.
51. Yu B, Wang Y, Liu Y, Liu Y, Li X, Wu D, Zong Z, Zhang J, Yu D. 2005. Protein kinase A regulates cell cycle progression of mouse fertilized eggs by means of MPF. Dev Dyn 232:98-105.
52. Yu A, Zhang Z, Bi Q, Sun B, Su W, Guan Y, Mu R, Miao C, Zhang J, Yu B. 2008. Regulation of cAMP on the first mitotic cell cycle of mouse embryos. Mol Reprod Dev 75:489-495.
53. Yuan ZQ, Sun M, Feldman RI, Wang G, Ma X, Jiang C, Coppola D, Nicosia SV, Cheng JQ. 2000. Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer. Oncogene 19: 2324-2330.
54. Zhang Z, Su WH, Feng C, Yu DH, Cui C, Xu XY, Yu BZ. 2007. Pololike kinase 1 may regulate G2/M transition of mouse fertilized eggs by means of inhibiting the phosphorylation of Tyr 15 of Cdc2. Mol Reprod Dev 74:1247-1254.